Gazpromneft-Lubricants and Enso Global Trading, one of the world's leading trading companies, signed a strategic cooperation agreement to broaden the distribution of lubricant assets across the South Asian region. The partnership provides for regular supplies of base, motor, hydraulic and gearbox oils for sale in the actively developing Indian market.
Enso Oils & Lubricants, a leading subsidiary of Enso Group, will specialize in the importation and distribution of Gazpromneft-Lubricants' high-quality oils, lubricants, and technical fluids that cater to a wide array of industries.
Vinay Maloo, Chairman, Enso Group said, “Enso is proud to be the strategic partner of Gazpromneft for their products and am sure that the relationship will bring positive gains to both entities.”
“Gazpromneft-Lubricants has world-class products in both automotive and industrial segments to fulfill the requirements of the Indian customers,” said Radhakrishnan Ramarathnam, CEO, Enso Oils & Lubricants.
The partnership will supplement the supply of specialized lubricants to India's largest manufacturers of industrial equipment and machinery, as well as other enterprises. For modern passenger vehicles manufactured in India, Gazpromneft-Lubricants will supply premium lines of engine and transmission oils with improved characteristics for reliable engine operation in hot climates. The company's own R&D department, including Russia’s only digital platform for developing oils based on artificial intelligence technology, ensures the uniqueness of the formulations.
Gazpromneft-Lubricants and Enso Global Trading Partner to Expand the Geography of Lubricant Supplies to the Global Market of the South Asian Region<br>

More to Read
Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
GAITHERSBURG, Md., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification valued at approximately $24 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), to supply CYFENDUS ® (Anthrax Vaccine Adsorbed, Adjuvanted) for anthrax preparedness efforts. Anthrax remains a significa
3 E Network Secures $1.2 Million Enterprise DDR4 Memory Sales Order
HONG KONG, Sept. 01, 2026 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3 E Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider, committed to becoming a next-generation artificial intelligence (“AI”) infrastructure solutions provider, today announced that its wholly owned subsidiary, 3e Network Technology Company Limited (“HK 3e Network”), has entered into a hardware sales agreement with an enterprise cl
Heidmar Maritime Holdings Corp. Reports Results for the Second Quarter Ended June 30, 2026
ATHENS, Greece and NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Heidmar Maritime Holdings Corp. (the "Company" or "Heidmar") (NASDAQ: HMR) today reported its results for the quarter and six month period ended June 30, 2026. Second Quarter 2026 Highlights Total revenues of $29.0 million, up from $9.6 million in Q2 2025 and up $10.6 million from Q1 2026. Net income attributable to shareholders of $2.2 million or $0.04 income per share, basic. Adjusted net income of $2.4 million, which excludes $0.
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
Building on positive Phase III results from the parties' AI-driven drug discovery program, the six-month Expansion Program will narrow the four validated compounds toward a nominated lead and designated backup. The Amendment also strengthens the exclusive Cardiac Disease and Obesity field of use and adds a right of first refusal across the broader cardiometabolic field. NEWPORT BEACH, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences Inc. ("NorthStrive Biosciences"), a subsidiar
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
ARLINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-registered precision health and clinical genomics company, today announced that they have entered into a letter of intent (the "LOI") outlining the principal terms under which the companies intend to negotiate a definitive agreement appointing Kala as the exclusive distributor and reseller in the United States of Virotek's genetic testing and screening program for opht
Polyaryletherketone Market Size to Surpass USD 1.94 Billion by 2035, Growing at 4.22% CAGR | SNS Insider
U.S. PAEK Market to Hit USD 0.29 Billion by 2035; Europe to Reach USD 0.81 Billion as Demand for Lightweight, Heat-Resistant Materials Rises Austin, Sept. 01, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Polyaryletherketone Market was valued at USD 1.28 Billion in 2025 and is expected to reach USD 1.94 Billion by 2035, growing at a CAGR of 4.22% from 2026 to 2035. Electronics continue to become smaller in size and the level of heat and strain associated with electronics continues to ri
USBC Expands Leadership Team with Former JPMorgan Chase and Coinbase Product Executive
Richa Pareek, new Chief Product Officer, to Lead USBC’s Next Phase of Platform Development RENO, Nev., Sept. 01, 2026 (GLOBE NEWSWIRE) -- USBC, Inc. (NYSE American: USBC) (“USBC” or the “Company”), a publicly traded technology company that seeks to enable the transformation of traditional U.S. bank dollars into secure, compliant tokenized deposits, today announced the appointment of Richa Pareek as Chief Product Officer. Pareek brings more than 15 years of payments and product development experi
Streamex Corp. Appoints Laura Kiernan as Head of Investor Relations
Award-winning Capital Markets Executive to Lead Investor Strategy and Shareholder Engagement WINTER PARK, Fla., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX) , a technology company building the future of the commodity markets through tokenization, today announced the appointment of Laura Kiernan, CPA, IRC, as Head of Investor Relations, effective September 2026. Ms. Kiernan will lead the Company’s investor relations strategy and serve as its prima
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!